SEM P 2MG/1.5ML 1S

SEM P 2MG/1.5ML Injection contains Semaglutide, a GLP-1 (Glucagon-Like Peptide-1) receptor agonist used for effective blood sugar control in Type 2 Diabetes Mellitus. It works by increasing insulin release when blood sugar is high, decreasing appetite, slowing gastric emptying, and reducing excess glucose production by the liver. This lower-strength dose is commonly used for dose initiation or maintenance therapy as prescribed by a healthcare professional.

Uses of SEM P 2MG/1.5ML Injection

• Treatment of Type 2 Diabetes Mellitus

• Glycemic control in diabetic patients

• Weight management (off-label, under medical advice)

• Reducing diabetes-related complications

Benefits

• Helps lower fasting and post-meal blood glucose

• Improves HbA1c levels

• Supports gradual and sustained weight loss

• Reduces appetite and food intake

• Convenient once-weekly injection

• Enhances patient treatment adherence

Side Effects

Common side effects may include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Abdominal pain

• Decreased appetite

• Headache

Serious but rare side effects:

• Pancreatitis (severe abdominal pain)

• Gallbladder disorders

• Allergic reactions

Precautions

• Use only on doctor’s prescription

• Not suitable for Type 1 diabetes

• Caution in patients with pancreatitis history

• Avoid during pregnancy and breastfeeding

• Regular blood glucose monitoring is advised

Storage Instructions

• Store in a refrigerator at 2°C–8°C

• Do not freeze

• Keep away from heat and direct light